A Study to Evaluate Clinical Characteristics of Lung Cancer in Patients With Surgeries and Adjuvant Therapies

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

21777 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-12-01

Study Completion Date

2018-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study was designed to evaluate effectiveness of the surgeries and adjuvant therapies after surgeries in the patients with lung malignant tumors

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study to Evaluate Effectiveness and Safety of Surgeries in Elderly NSCLC Patients

NCT03429673

Non-small Cell Lung Cancer

COMPLETED

A Study to Explore Prognoses of the Patients With N2 Non-small Cell Lung Cancer

NCT03451526

Non-small Cell Lung Cancer

COMPLETED

A Study to Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung Cancer

NCT03427567

Non-small Cell Lung Cancer

COMPLETED

A Study to Explore Prognoses of NSCLC Patients Complicated With Oligometastases

NCT03427541

Non Small Cell Lung Cancer

UNKNOWN

Real-world Clinical Outcomes of Patients With Early-stage Lung Cancer After the Surgery

NCT06483698

Lung Cancer

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The trial is a multi-centre real-world non-interventional observational study to evaluate effectiveness of the surgeries and adjuvant therapies after surgeries in the patients with lung malignant tumors via a retrospectively review method on the study data on patient demographic/tumor biological characteristics and clinical treatments.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Surgeries and adjuvant therapies

Surgeries or surgeries plus adjuvant therapies

Surgeries

Intervention Type PROCEDURE

Surgeries or surgeries plus adjuvant therapies

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Surgeries

Surgeries or surgeries plus adjuvant therapies

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Adjuvant therapies

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \>= 18 years old;
* Pathologically diagnosed lung malignant tumors after surgeries;
* Patients with lung surgeries;
* Patients with complete medical health records and follow-up visit information (at least one follow-up visit);